Best Shock Strength for Treating Irregular Heartbeat
Treatments studied
Part of Heart & circulation clinical trials.
This study tests different levels of electrical shock to find the safest and most effective way to restore a normal heartbeat in patients with atrial fibrillation or atypical atrial flutter. The goal is to improve outcomes and reduce the energy needed for treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with atrial fibrillation (irregular heartbeat in the heart's upper chambers) or atypical atrial flutter (a less common irregular rhythm)
- Your doctor has recommended electrical cardioversion (a controlled electrical shock to reset your heart rhythm) as a treatment
- The cardioversion is planned as an elective procedure (scheduled in advance, not an emergency)
- You do not have typical atrial flutter (a different type of irregular rhythm that would make you ineligible)
- You do not have focal atrial tachycardia (a different heart rhythm condition)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method using two electrical shocks to help restore a normal heart rhythm in patients with persistent atrial fibrillation (a condition where the heart's upper chambers beat irregularly). The goal is to see if this technique is safe and effective.
This trial uses a procedure called electrical cardioversion (a controlled shock to restore a normal heart rhythm) to see if treating atrial fibrillation or atrial flutter can improve symptoms in people with heart failure. The goal is to find out if fixing the irregular heartbeat helps you breathe better, have more energy, and feel better overall.
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
This study follows patients getting a newer heart rhythm treatment called pulsed field ablation for atrial fibrillation (an irregular heartbeat). Researchers want to understand which patients do well long-term and which may need additional treatment.
This trial tests whether using a specific “shock energy” during electrical cardioversion works safely and effectively for people with persistent atrial fibrillation. You might be eligible if your cardioversion is planned (not an emergency) and your doctors determine you can safely take blood thinners.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.